Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Galina Shamayeva

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Metallomics : Integrated Biometal Science|January 6, 2018
Iron reduction response and demographic differences between diabetics and non-diabetics with cardiovascular disease entered into a controlled clinical trialLeo R Zacharski, Galina Shamayeva, Bruce K Chow
American Heart Journal|November 19, 2011
Effect of controlled reduction of body iron stores on clinical outcomes in peripheral arterial diseaseLeo R Zacharski, Galina Shamayeva, Bruce K Chow
Journal of Health Care for the Poor and Underserved|February 24, 2015
Racial differences in iron measures and outcomes observed during an iron reduction trial in peripheral arterial diseaseLeo R Zacharski, Galina Shamayeva, Bruce K Chow, et al.
Journal of Health Care for the Poor and Underserved|May 17, 2016
Racial Health Disparities, and Variant Red Cell and Iron HomeostasisLeo R Zacharski, Galina Shamayeva, Bruce K Chow, et al.
Current Diabetes Reviews|May 6, 2017
Ferritin and Percent Transferrin Saturation Levels Predict Type 2 Diabetes Risk and Cardiovascular Disease OutcomesLeo R Zacharski, Galina Shamayeva, Bruce K Chow, et al.
American Journal of Public Health|February 16, 2013
The statin-iron nexus: anti-inflammatory intervention for arterial disease preventionLeo R Zacharski, Ralph G DePalma, Galina Shamayeva, et al.
Vascular|March 23, 2013
Reduction of iron stores and clinical outcomes in peripheral arterial disease: outcome comparisons in smokers and non-smokersRalph G DePalma, Leo R Zacharski, Bruce K Chow, et al.
American Heart Journal|September 25, 2004
Implementation of an iron reduction protocol in patients with peripheral vascular disease: VA cooperative study no. 410: the Iron (Fe) and Atherosclerosis Study (FeAST)Leo R Zacharski, Bruce K Chow, Paula S Howes, et al.
Journal of Vascular Surgery|March 23, 2010
Ferritin levels, inflammatory biomarkers, and mortality in peripheral arterial disease: a substudy of the Iron (Fe) and Atherosclerosis Study (FeAST) TrialRalph G Depalma, Virginia W Hayes, Bruce K Chow, et al.
Journal of the National Cancer Institute|July 10, 2008
Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trialLeo R Zacharski, Bruce K Chow, Paula S Howes, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Metallomics : Integrated Biometal Science|January 6, 2018
Iron reduction response and demographic differences between diabetics and non-diabetics with cardiovascular disease entered into a controlled clinical trialLeo R Zacharski, Galina Shamayeva, Bruce K Chow
American Heart Journal|November 19, 2011
Effect of controlled reduction of body iron stores on clinical outcomes in peripheral arterial diseaseLeo R Zacharski, Galina Shamayeva, Bruce K Chow
Journal of Health Care for the Poor and Underserved|February 24, 2015
Racial differences in iron measures and outcomes observed during an iron reduction trial in peripheral arterial diseaseLeo R Zacharski, Galina Shamayeva, Bruce K Chow, et al.
Journal of Health Care for the Poor and Underserved|May 17, 2016
Racial Health Disparities, and Variant Red Cell and Iron HomeostasisLeo R Zacharski, Galina Shamayeva, Bruce K Chow, et al.
Current Diabetes Reviews|May 6, 2017
Ferritin and Percent Transferrin Saturation Levels Predict Type 2 Diabetes Risk and Cardiovascular Disease OutcomesLeo R Zacharski, Galina Shamayeva, Bruce K Chow, et al.
American Journal of Public Health|February 16, 2013
The statin-iron nexus: anti-inflammatory intervention for arterial disease preventionLeo R Zacharski, Ralph G DePalma, Galina Shamayeva, et al.
Vascular|March 23, 2013
Reduction of iron stores and clinical outcomes in peripheral arterial disease: outcome comparisons in smokers and non-smokersRalph G DePalma, Leo R Zacharski, Bruce K Chow, et al.
American Heart Journal|September 25, 2004
Implementation of an iron reduction protocol in patients with peripheral vascular disease: VA cooperative study no. 410: the Iron (Fe) and Atherosclerosis Study (FeAST)Leo R Zacharski, Bruce K Chow, Paula S Howes, et al.
Journal of Vascular Surgery|March 23, 2010
Ferritin levels, inflammatory biomarkers, and mortality in peripheral arterial disease: a substudy of the Iron (Fe) and Atherosclerosis Study (FeAST) TrialRalph G Depalma, Virginia W Hayes, Bruce K Chow, et al.
Journal of the National Cancer Institute|July 10, 2008
Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trialLeo R Zacharski, Bruce K Chow, Paula S Howes, et al.
Pageof 2